Table 1. Vascular Disrupting Agents Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Vascular Disrupting Agents Market Restraints

Table 3. Vascular Disrupting Agents Market Trends

Table 4. Vascular Disrupting Agents Industry Policy

Table 5. Global Vascular Disrupting Agents Revenue by Company, 2019-2023, US$ million

Table 6. Global Vascular Disrupting Agents Revenue Market Share by Company, 2019-2023

Table 7. Global Vascular Disrupting Agents Sales Volume by Company, 2019-2023, (K Units)

Table 8. Global Vascular Disrupting Agents Sales Volume Market Share by Company, 2019-2023

Table 9. Global Vascular Disrupting Agents Price by Company, 2019-2023, (US$/Unit)

Table 10. Global Vascular Disrupting Agents Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Vascular Disrupting Agents Mergers & Acquisitions, Expansion Plans

Table 12. Global Vascular Disrupting Agents Manufacturers Product Type

Table 13. China Vascular Disrupting Agents Revenue by Company, 2019-2023, US$ million

Table 14. China Vascular Disrupting Agents Revenue Market Share by Company, 2019-2023

Table 15. China Vascular Disrupting Agents Sales Volume by Company, 2019-2023, (K Units)

Table 16. China Vascular Disrupting Agents Sales Volume Market Share by Company, 2019-2023

Table 17. China Market, Vascular Disrupting Agents Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Vascular Disrupting Agents Import & Export Trends

Table 19. Main Sources of China Vascular Disrupting Agents Import

Table 20. Export Destination of China Vascular Disrupting Agents

Table 21. Global Headquarters and Manufacturing Base of Vascular Disrupting Agents Manufacturers

Table 22. Global Major Manufacturers, Vascular Disrupting Agents Capacity Expansion and Future Plans

Table 23. Global Vascular Disrupting Agents Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)

Table 24. Global Vascular Disrupting Agents Production by Region, 2019-2023, (K Units)

Table 25. Global Vascular Disrupting Agents Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Vascular Disrupting Agents Upstream (Raw Materials)

Table 27. Global Vascular Disrupting Agents Typical Customers

Table 28. Vascular Disrupting Agents Typical Distributors

Table 29. By Type, Global Vascular Disrupting Agents Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 30. By Application, Global Vascular Disrupting Agents Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 31. By Region, Global Vascular Disrupting Agents Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 32. By Region, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Vascular Disrupting Agents Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 35. By Country, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030

Table 37. By Country, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030

Table 39. AGC Biologics Company Information, Head Office, Market Area and Industry Position

Table 40. AGC Biologics Vascular Disrupting Agents Models, Specifications and Application

Table 41. AGC Biologics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 42. AGC Biologics Company Profile and Main Business

Table 43. AGC Biologics Recent Developments

Table 44. Avid Bioservices Company Information, Head Office, Market Area and Industry Position

Table 45. Avid Bioservices Vascular Disrupting Agents Models, Specifications and Application

Table 46. Avid Bioservices Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 47. Avid Bioservices Company Profile and Main Business

Table 48. Avid Bioservices Recent Developments

Table 49. Bionomics Company Information, Head Office, Market Area and Industry Position

Table 50. Bionomics Vascular Disrupting Agents Models, Specifications and Application

Table 51. Bionomics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 52. Bionomics Company Profile and Main Business

Table 53. Bionomics Recent Developments

Table 54. Beijing Shenogen Biomedical Company Information, Head Office, Market Area and Industry Position

Table 55. Beijing Shenogen Biomedical Vascular Disrupting Agents Models, Specifications and Application

Table 56. Beijing Shenogen Biomedical Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 57. Beijing Shenogen Biomedical Company Profile and Main Business

Table 58. Beijing Shenogen Biomedical Recent Developments

Table 59. Mateon Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 60. Mateon Therapeutics Vascular Disrupting Agents Models, Specifications and Application

Table 61. Mateon Therapeutics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 62. Mateon Therapeutics Company Profile and Main Business

Table 63. Mateon Therapeutics Recent Developments

Table 64. Myrexis Company Information, Head Office, Market Area and Industry Position

Table 65. Myrexis Vascular Disrupting Agents Models, Specifications and Application

Table 66. Myrexis Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 67. Myrexis Company Profile and Main Business

Table 68. Myrexis Recent Developments

Table 69. VBL Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 70. VBL Therapeutics Vascular Disrupting Agents Models, Specifications and Application

Table 71. VBL Therapeutics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 72. VBL Therapeutics Company Profile and Main Business

Table 73. VBL Therapeutics Recent Developments

Table 74. Steba biotech Company Information, Head Office, Market Area and Industry Position

Table 75. Steba biotech Vascular Disrupting Agents Models, Specifications and Application

Table 76. Steba biotech Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 77. Steba biotech Company Profile and Main Business

Table 78. Steba biotech Recent Developments

Table 79. BeyondSpring Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 80. BeyondSpring Pharmaceutical Vascular Disrupting Agents Models, Specifications and Application

Table 81. BeyondSpring Pharmaceutical Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 82. BeyondSpring Pharmaceutical Company Profile and Main Business

Table 83. BeyondSpring Pharmaceutical Recent Developments

Table 84. Immune Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 85. Immune Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

Table 86. Immune Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 87. Immune Pharmaceuticals Company Profile and Main Business

Table 88. Immune Pharmaceuticals Recent Developments

Table 89. Nereus Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 90. Nereus Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

Table 91. Nereus Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 92. Nereus Pharmaceuticals Company Profile and Main Business

Table 93. Nereus Pharmaceuticals Recent Developments

Table 94. Madrigal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 95. Madrigal Pharmaceuticals Vascular Disrupting Agents Models, Specifications and Application

Table 96. Madrigal Pharmaceuticals Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 97. Madrigal Pharmaceuticals Company Profile and Main Business

Table 98. Madrigal Pharmaceuticals Recent Developments

Table 99. Celgene Corporation Company Information, Head Office, Market Area and Industry Position

Table 100. Celgene Corporation Vascular Disrupting Agents Models, Specifications and Application

Table 101. Celgene Corporation Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 102. Celgene Corporation Company Profile and Main Business

Table 103. Celgene Corporation Recent Developments

Table 104. Bionomics Company Information, Head Office, Market Area and Industry Position

Table 105. Bionomics Vascular Disrupting Agents Models, Specifications and Application

Table 106. Bionomics Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 107. Bionomics Company Profile and Main Business

Table 108. Bionomics Recent Developments

Table 109. Lees Pharmaceutical Holdings Company Information, Head Office, Market Area and Industry Position

Table 110. Lees Pharmaceutical Holdings Vascular Disrupting Agents Models, Specifications and Application

Table 111. Lees Pharmaceutical Holdings Vascular Disrupting Agents Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 112. Lees Pharmaceutical Holdings Company Profile and Main Business

Table 113. Lees Pharmaceutical Holdings Recent Developments

List of Figure

Figure 1. Vascular Disrupting Agents Picture

Figure 2. By Revenue, Global Vascular Disrupting Agents Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Vascular Disrupting Agents Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Vascular Disrupting Agents Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Vascular Disrupting Agents Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Vascular Disrupting Agents Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Vascular Disrupting Agents Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Vascular Disrupting Agents Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Vascular Disrupting Agents Share of Global Market, 2019-2030

Figure 10. Global Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 11. Global Vascular Disrupting Agents Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023

Figure 12. China Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 13. China Vascular Disrupting Agents Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 14. China Vascular Disrupting Agents Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 15. Chinese Local Players, Proportion of Vascular Disrupting Agents Domestic VS Export, 2023

Figure 16. Global Vascular Disrupting Agents Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Vascular Disrupting Agents Capacity Market Share by Region, 2023 VS 2030

Figure 18. Global Vascular Disrupting Agents Production Market Share & Forecast by Region, 2019-2030

Figure 19. Vascular Disrupting Agents Industry Chain

Figure 20. Vascular Disrupting Agents Procurement Model

Figure 21. Vascular Disrupting Agents Sales Model

Figure 22. Vascular Disrupting Agents Sales Channels, Direct Sales and Distribution

Figure 23. Oral

Figure 24. Vein

Figure 25. By Type, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030

Figure 27. By Type, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Vascular Disrupting Agents Price, 2019-2030, (US$/Unit)

Figure 30. Hospital

Figure 31. Specialty Clinic

Figure 32. Others

Figure 33. By Application, Global Vascular Disrupting Agents Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030

Figure 35. By Application, Global Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global Vascular Disrupting Agents Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global Vascular Disrupting Agents Revenue Market Share, 2019-2030

Figure 39. By Region, Global Vascular Disrupting Agents Sales Volume Market Share, 2019-2030

Figure 40. North America Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America Vascular Disrupting Agents Revenue Market Share, 2023

Figure 42. Europe Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe Vascular Disrupting Agents Revenue Market Share, 2023

Figure 44. Asia Pacific Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific Vascular Disrupting Agents Revenue Market Share, 2023

Figure 46. South America Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America Vascular Disrupting Agents Revenue Market Share, 2023

Figure 48. Middle East & Africa Vascular Disrupting Agents Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. Vascular Disrupting Agents Market Share, 2023

Figure 51. By Type, U.S. Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 52. By Application, U.S. Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 53. Europe Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe Vascular Disrupting Agents Market Share, 2023

Figure 55. By Type, Europe Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 56. By Application, Europe Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 57. China Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China Vascular Disrupting Agents Market Share, 2023

Figure 59. By Type, China Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 60. By Application, China Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 61. Japan Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan Vascular Disrupting Agents Market Share, 2023

Figure 63. By Type, Japan Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 64. By Application, Japan Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 65. South Korea Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea Vascular Disrupting Agents Market Share, 2023

Figure 67. By Type, South Korea Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 68. By Application, South Korea Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 69. Southeast Asia Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia Vascular Disrupting Agents Market Share, 2023

Figure 71. By Type, Southeast Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 72. By Application, Southeast Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 73. India Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India Vascular Disrupting Agents Market Share, 2023

Figure 75. By Type, India Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 76. By Application, India Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 77. Middle East & Asia Vascular Disrupting Agents Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia Vascular Disrupting Agents Market Share, 2023

Figure 79. By Type, Middle East & Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 80. By Application, Middle East & Asia Vascular Disrupting Agents Sales Volume Market Share, 2023 VS 2030

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches